Application of recombined human vascellum esoderma inhibin in medicine preparation
OA: closed
Abstract
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endothelium inhibin can specifically inhibit neovascular proliferation of ectopic focus and has the advantages of innocuity safety, no drug resistance, significant effect on combined surgery or other pharmaceutical treatments, high curative rate and good application potential.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-07-07T06:07:59.301721+00:00